Tirofiban patient counseling information: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Tirofiban}} {{CMG}}; {{AE}} {{SS}} ==Patient Counseling Information== Advise patients to watch closely for any signs of bleeding or bruising and to report these ...")
 
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Tirofiban#Patient Counseling Information]]
{{Tirofiban}}
{{CMG}}; {{AE}} {{SS}}
 
==Patient Counseling Information==
 
Advise patients to watch closely for any signs of bleeding or bruising and to report these to their health care provider when they occur.
 
Advise patients to discuss with their health care provider their use of any other medications, including over-the-counter or herbal products prior to AGGRASTAT use.
 
Patent: www.medicure.com/aggrastat/patents
 
AGGRASTAT is manufactured for:
 
MEDICURE INTERNATIONAL, INC.
 
by:
 
BAXTER HEALTHCARE CORPORATION
 
Deerfield, Illinois 60015 USA
 
Distributed by:
 
MEDICURE PHARMA, INC.
Somerset, NJ 08873 USA
1-800-509-0544
Printed in USA
07-19-72-370
* Registered trademark of Medicure International Inc.
© 2013
Copyright used under license.
All rights reserved.
Intravia is a registered trademark of Baxter International Inc.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = AGGRASTAT (TIROFIBAN) INJECTION, SOLUTION [MEDICURE INTERNATIONAL INC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe0ced75-ccbf-4d2e-bd0d-b57e60ab913f | publisher =  | date =  | accessdate = 6 February 2014 }}</ref>
 
==References==
 
{{Reflist|2}}
 
[[Category:Antiplatelet drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 02:53, 22 July 2014